{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:15:49Z","timestamp":1786720549361,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/aps.2015.150","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T10:01:50Z","timestamp":1458554510000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Carbocisteine attenuates TNF-\u03b1-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-\u03baB and ERK1\/2 MAPK signaling pathways"],"prefix":"10.1038","volume":"37","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-quan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"BFaps2015150_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1532-5415.2005.00592_9.x","volume":"54","author":"H Yasuda","year":"2006","unstructured":"Yasuda H, Yamaya M, Sasaki T, Inoue D, Nakayama K, Tomita N, et al. Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2006; 54: 378\u201380.","journal-title":"J Am Geriatr Soc"},{"key":"BFaps2015150_CR2","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1532-5415.2007.01373.x","volume":"55","author":"K Tatsumi","year":"2007","unstructured":"Tatsumi K, Fukuchi Y . Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2007; 55: 1884\u20136.","journal-title":"J Am Geriatr Soc"},{"key":"BFaps2015150_CR3","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","volume":"371","author":"JP Zheng","year":"2008","unstructured":"Zheng JP, Kang J, Huang SG, Chen P, Yao WZ, Yang L, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 2008; 371: 2013\u20138.","journal-title":"Lancet"},{"key":"BFaps2015150_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1440-1843.2008.01424.x","volume":"14","author":"H Nogawa","year":"2009","unstructured":"Nogawa H, Ishibashi Y, Ogawa A, Masuda K, Tsubuki T, Kameda T, et al. Carbocisteine can scavenge reactive oxygen species in vitro. Respirology 2009; 14: 53\u20139.","journal-title":"Respirology"},{"key":"BFaps2015150_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12192-013-0424-0","volume":"18","author":"E Pace","year":"2013","unstructured":"Pace E, Ferraro M, Di Vincenzo S, Cipollina C, Gerbino S, Cigna D, et al. Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells. Cell Stress Chaperones 2013; 18: 733\u201343.","journal-title":"Cell Stress Chaperones"},{"key":"BFaps2015150_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1440-1843.2009.01594.x","volume":"14","author":"M Yoshida","year":"2009","unstructured":"Yoshida M, Nakayama K, Yasuda H, Kubo H, Kuwano K, Arai H, et al. Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells. Respirology 2009; 14: 1027\u201334.","journal-title":"Respirology"},{"key":"BFaps2015150_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1183\/09031936.06.00058505","volume":"28","author":"H Yasuda","year":"2006","unstructured":"Yasuda H, Yamaya M, Sasaki T, Inoue D, Nakayama K, Yamada M, et al. Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells. Eur Respir J 2006; 28: 51\u20138.","journal-title":"Eur Respir J"},{"key":"BFaps2015150_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.resp.2011.10.017","volume":"180","author":"M Asada","year":"2012","unstructured":"Asada M, Yoshida M, Hatachi Y, Sasaki T, Yasuda H, Deng X, et al. l-carbocisteine inhibits respiratory syncytial virus infection in human tracheal epithelial cells. Respir Physiol Neurobiol 2012; 180: 112\u20138.","journal-title":"Respir Physiol Neurobiol"},{"key":"BFaps2015150_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.coph.2012.01.015","volume":"12","author":"I Rahman","year":"2012","unstructured":"Rahman I, MacNee W . Antioxidant pharmacological therapies for COPD. Curr Opin Pharmacol 2012; 12: 256\u201365.","journal-title":"Curr Opin Pharmacol"},{"key":"BFaps2015150_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.intimp.2014.12.018","volume":"24","author":"W Wang","year":"2015","unstructured":"Wang W, Zheng JP, Zhu SX, Guan WJ, Chen M, Zhong NS . Carbocisteine attenuates hydrogen peroxide-induced inflammatory injury in A549 cells via NF-kappaB and ERK1\/2 MAPK pathways. Int Immunopharmacol 2015; 24: 306\u201313.","journal-title":"Int Immunopharmacol"},{"key":"BFaps2015150_CR11","first-page":"137","volume":"56","author":"M Vitacca","year":"2001","unstructured":"Vitacca M . Exacerbations of COPD: predictive factors, treatment and outcome. Monaldi Arch Chest Dis 2001; 56: 137\u201343.","journal-title":"Monaldi Arch Chest Dis"},{"key":"BFaps2015150_CR12","doi-asserted-by":"publisher","first-page":"136S","DOI":"10.1378\/chest.121.5_suppl.136S","volume":"121","author":"JA Wedzicha","year":"2002","unstructured":"Wedzicha JA . Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002; 121: 136S\u201341S.","journal-title":"Chest"},{"key":"BFaps2015150_CR13","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1183\/09031936.00063112","volume":"41","author":"DM Comer","year":"2013","unstructured":"Comer DM, Kidney JC, Ennis M, Elborn JS . Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J 2013; 41: 1058\u201367.","journal-title":"Eur Respir J"},{"key":"BFaps2015150_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1164\/ajrccm.150.5.7952575","volume":"150","author":"M Di Francia","year":"1994","unstructured":"Di Francia M, Barbier D, Mege JL, Orehek J . Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFaps2015150_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1517\/13543784.17.8.1203","volume":"17","author":"SA Antoniu","year":"2008","unstructured":"Antoniu SA, Mihaltan F, Ulmeanu R . Anti-TNF-alpha therapies in chronic obstructive pulmonary diseases. Expert Opin Investig Drugs 2008; 17: 1203\u201311.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFaps2015150_CR16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/ajrccm.161.4.9903022","volume":"161","author":"N Takabatake","year":"2000","unstructured":"Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1179\u201384.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFaps2015150_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1165\/rcmb.2012-0287OC","volume":"49","author":"J Knobloch","year":"2013","unstructured":"Knobloch J, Lin Y, Konradi J, Jungck D, Behr J, Strauch J, et al. Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism. Am J Respir Cell Mol Biol 2013; 49: 114\u201327.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFaps2015150_CR18","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s10753-014-9928-8","volume":"37","author":"W Chunlian","year":"2014","unstructured":"Chunlian W, Heyong W, Jia X, Jie H, Xi C, Gentao L . Magnolol inhibits tumor necrosis factor-alpha-induced ICAM-1 expression via suppressing NF-kappaB and MAPK signaling pathways in human lung epithelial cells. Inflammation 2014; 37: 1957\u201367.","journal-title":"Inflammation"},{"key":"BFaps2015150_CR19","doi-asserted-by":"publisher","first-page":"L741","DOI":"10.1152\/ajplung.00208.2003","volume":"286","author":"WD Hardie","year":"2004","unstructured":"Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR . Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2004; 286: L741\u20139.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFaps2015150_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101\u20138.","journal-title":"Nat Protoc"},{"key":"BFaps2015150_CR21","doi-asserted-by":"publisher","first-page":"41549","DOI":"10.1074\/jbc.M110.193383","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Finkelstein D, Li X, Wu D, Shi DL, Zheng JJ . Identification of transmembrane protein 88 (TMEM88) as a dishevelled-binding protein. J Biol Chem 2010; 285: 41549\u201356.","journal-title":"J Biol Chem"},{"key":"BFaps2015150_CR22","first-page":"397","volume":"9","author":"G Caramori","year":"2014","unstructured":"Caramori G, Adcock IM, Di Stefano A, Chung KF . Cytokine inhibition in the treatment of COPD. Int J Chron Obstruct Pulmon Dis 2014; 9: 397\u2013412.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"BFaps2015150_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1378\/chest.09-1541","volume":"137","author":"JK Quint","year":"2010","unstructured":"Quint JK, Donaldson GC, Goldring JJ, Baghai-Ravary R, Hurst JR, Wedzicha JA, et al. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Chest 2010; 137: 812\u201322.","journal-title":"Chest"},{"key":"BFaps2015150_CR24","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.2174\/09298673113206660261","volume":"20","author":"G Caramori","year":"2013","unstructured":"Caramori G, Di Stefano A, Casolari P, Kirkham PA, Padovani A, Chung KF, et al. Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease. Curr Med Chem 2013; 20: 4317\u201349.","journal-title":"Curr Med Chem"},{"key":"BFaps2015150_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1753425911423270","volume":"18","author":"K Blidberg","year":"2012","unstructured":"Blidberg K, Palmberg L, Dahlen B, Lantz AS, Larsson K . Chemokine release by neutrophils in chronic obstructive pulmonary disease. Innate Immun 2012; 18: 503\u201310.","journal-title":"Innate Immun"},{"key":"BFaps2015150_CR26","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1172\/JCI24858","volume":"115","author":"B Ma","year":"2005","unstructured":"Ma B, Kang MJ, Lee CG, Chapoval S, Liu W, Chen Q, et al. Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J Clin Invest 2005; 115: 3460\u201372.","journal-title":"J Clin Invest"},{"key":"BFaps2015150_CR27","doi-asserted-by":"publisher","first-page":"L160","DOI":"10.1152\/ajplung.00376.2009","volume":"299","author":"M Yamaya","year":"2010","unstructured":"Yamaya M, Nishimura H, Shinya K, Hatachi Y, Sasaki T, Yasuda H, et al. Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2010; 299: L160\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFaps2015150_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1006\/abbi.2000.1770","volume":"377","author":"RR Roussel","year":"2000","unstructured":"Roussel RR, Barchowsky A . Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation. Arch Biochem Biophys 2000; 377: 204\u201312.","journal-title":"Arch Biochem Biophys"},{"key":"BFaps2015150_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2012.10.016","volume":"68","author":"ZP Xu","year":"2013","unstructured":"Xu ZP, Devillier P, Xu GN, Qi H, Zhu L, Zhou W, et al. TNF-alpha-induced CXCL8 production by A549 cells: involvement of the non-neuronal cholinergic system. Pharmacol Res 2013; 68: 16\u201323.","journal-title":"Pharmacol Res"},{"key":"BFaps2015150_CR30","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL . Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 1999; 18: 6853\u201366.","journal-title":"Oncogene"},{"key":"BFaps2015150_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0898-6568(94)90041-8","volume":"6","author":"KL Guan","year":"1994","unstructured":"Guan KL . The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal 1994; 6: 581\u20139.","journal-title":"Cell Signal"},{"key":"BFaps2015150_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1378\/chest.06-0668","volume":"131","author":"VM Pinto-Plata","year":"2007","unstructured":"Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007; 131: 37\u201343.","journal-title":"Chest"},{"key":"BFaps2015150_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.arbres.2010.12.003","volume":"47","author":"AL Kersul","year":"2011","unstructured":"Kersul AL, Iglesias A, Rios A, Noguera A, Forteza A, Serra E, et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2011; 47: 176\u201383.","journal-title":"Arch Bronconeumol"},{"key":"BFaps2015150_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S2213-2600(13)70286-8","volume":"2","author":"JP Zheng","year":"2014","unstructured":"Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med 2014; 2: 187\u201394.","journal-title":"Lancet Respir Med"},{"key":"BFaps2015150_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1378\/chest.12-2357","volume":"144","author":"HN Tse","year":"2013","unstructured":"Tse HN, Raiteri L, Wong KY, Yee KS, Ng LY, Wai KY, et al. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest 2013; 144: 106\u201318.","journal-title":"Chest"},{"key":"BFaps2015150_CR36","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","volume":"365","author":"M Decramer","year":"2005","unstructured":"Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005; 365: 1552\u201360.","journal-title":"Lancet"},{"key":"BFaps2015150_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1513\/pats.201201-009MS","volume":"9","author":"S Biswal","year":"2012","unstructured":"Biswal S, Thimmulappa RK, Harvey CJ . Experimental therapeutics of Nrf2 as a target for prevention of bacterial exacerbations in COPD. Proc Am Thorac Soc 2012; 9: 47\u201351.","journal-title":"Proc Am Thorac Soc"},{"key":"BFaps2015150_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.molmed.2011.02.006","volume":"17","author":"A Boutten","year":"2011","unstructured":"Boutten A, Goven D, Artaud-Macari E, Boczkowski J, Bonay M . NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol Med 2011; 17: 363\u201371.","journal-title":"Trends Mol Med"},{"key":"BFaps2015150_CR39","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bcp.2007.01.004","volume":"73","author":"HS Zhang","year":"2007","unstructured":"Zhang HS, Wang SQ . Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem Pharmacol 2007; 73: 1358\u201366.","journal-title":"Biochem Pharmacol"},{"key":"BFaps2015150_CR40","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1165\/rcmb.2012-0292OC","volume":"50","author":"Y Yageta","year":"2014","unstructured":"Yageta Y, Ishii Y, Morishima Y, Ano S, Ohtsuka S, Matsuyama M, et al. Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke. Am J Respir Cell Mol Biol 2014; 50: 963\u201373.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2015150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2015150","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2015150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:32:46Z","timestamp":1684413166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2015150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFaps2015150"],"URL":"https:\/\/doi.org\/10.1038\/aps.2015.150","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]},"assertion":[{"value":"23 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}